MedTrace Logo

Effect of a Mobile App on Improving Asthma Control in Patients With Persistent Asthma

NCT05129527 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2023-10-19

No results posted yet for this study

Summary

mINSPIRERS\_RCT aims to assess the magnitude of the effect of a mobile app for improving asthma control in adolescents and adults with persistent asthma, followed at primary and secondary care in Portugal.

Conditions

Interventions

DEVICE

InspirerMundi app

Patients in the experimental group, in addition to usual care, will be invited to use the InspirerMundi app for 4 months to support adherence to preventive inhaled medication and their asthma self-management. The purpose of the InspirerMundi app is to transform the adherence process into a positive experience through immediate and pleasant rewards. The InspirerMundi app integrates 3 main components: monitoring (symptoms, control, adherence), gaming and social/peer support. Participants will be able to include their action plan in the app. Within the action plan, the application can lead to changes in the medication effectively taken, which means that the therapeutic level can be adjusted according to the action plan. Participants in the experimental arm will be able to share with their physician, through the app, their medication adherence and asthma control data in the 3 months visit, and whenever patients wish during the study period.

OTHER

Usual care

Usual care will consist of pharmacological treatment and medical monitoring through routine medical visits.

Sponsors & Collaborators

  • Centro de Investigação em Tecnologias e Serviços de Saúde

    collaborator OTHER

  • Rede de Investigação em Saúde

    collaborator OTHER

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • João Almeida Fonseca, PhD · Universidade do Porto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-10-31
Completion
2024-12-31

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05129527 on ClinicalTrials.gov